Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

Gretchen Henkel  |  Issue: September 2013  |  September 1, 2013

Taking the Measure of RHEUM
Rheumatology colleagues (left to right) Drs. Josef S. Smolen, Paul Emery, Désirée van der Heijde, Maxime Dougados, and F. C. Breedveld.
Click here to listen in.


Among his many national and international collaborators, Maxime Dougados, MD, professor of rheumatology at René Descartes University and Hôpital Cochin in Paris, has earned a reputation as an innovator. Josef S. Smolen, MD, chair of the division of rheumatology at the Medical University of Vienna in Austria and chair of the second department of medicine at the Center for Rheumatic Diseases at Hietzing Hospital in Vienna, has known Dr. Dougados for about 20 years. It was during Dr. Smolen’s term as president of the European League Against Rheumatism (EULAR), beginning in 2003, that their interactions intensified. Dr. Dougados had just become chair of the Standing Committee for Clinical Trials. “That was a very pleasant time,” says Dr. Smolen, “because [Dr. Dougados] was extremely smart, extremely structured, and very evidence driven. He made a number of terrific proposals that the executive committee could all support, developing points to consider regarding how to produce recommendations and consensus statements.”

Dr. Dougados’ interest in clinical measurement took hold early in his medical career, and he has combined that interest with what Dr. Smolen calls “a talent for the group process.” EULAR is now benefitting from that talent, as Dr. Dougados guides the organization as its current president. “He doesn’t go into discussions with preconceived or mandated opinions,” says Dr. Smolen, “but rather open for discussion and flexible.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A visionary, a doer, a change agent: Dr. Dougados has carved a wide swath in the international sphere in rheumatology. By his own account, Dr. Dougados came from humble circumstances, growing up in the countryside in the south of France. As a young boy, he dreamt of becoming a teacher. However, during secondary school, his sister had a boyfriend who was studying medicine, and who also came from modest beginnings. He told the 15-year-old Maxime: “You can do this, too.”

“I was attracted to medicine because of the possibility to have a human relationship in the job. I had in mind never to work alone in an office, but to work in connection with people,” Dr. Dougados says. “So, thanks to the French public school system, my parents did not have to pay [for schooling].”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bonne Chance in Rheumatology

Dr. Dougados began his medical training in Bordeaux, initially intending to become a surgeon. By his third year as a medical student, however, he found that, “it was much more challenging and exciting to be a clinician.” And then, in his fourth year of training, he married and moved to Paris to continue medical school. His first practicum was in rheumatology—and, as it happened, he landed in Bernard Amor’s department. Dr. Dougados was so impressed with his mentor (“he was very clever, precise, rigorous, and considered the patient suffering from rheumatic disease as a whole person,” Dr. Dougados says) that he immediately decided to become a rheumatologist. He was only 20 years old at the time.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisPractice SupportProfiles

Related Articles

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    “A Common Language for Spondyloarthritis”

    December 1, 2010

    ASAS fills a niche, changes dogma with consensus approach

    The Key to Early Rheumatoid Arthritis

    September 1, 2010

    The conundrum of classification versus diagnosis

    Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

    September 11, 2020

    EULAR 2020 e-CONGRESS—In what speakers at the European e-Congress of Rheumatology described as the first treat-to-target and tight control (T2T/TC) strategy trial in axial spondyloarthritis (AxSpA), researchers found such a strategy has both health and financial benefits. In the year-long study—called TICOSPA—centers were randomized to apply either a T2T/TC strategy or care left to the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences